ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Radiation Oncology

Rethinking Radiation: Adopting Hypofractionated Radiation Therapy

Haleigh Behrman
on: June 10, 2025In: Evolving Standards of Care, Radiation Oncology
Rethinking Radiation: Adopting Hypofractionated Radiation Therapy

Drs. Puneeth Iyengar and Edward Christopher Dee discuss the potential clinical and environmental benefits of hypofractionated radiation therapy, along with the barriers to broader adoption. Read more


The Elephant in the Room: Addressing Oncology’s Carbon Footprint

Haleigh Behrman
on: May 13, 2025In: Evolving Standards of Care, Radiation Oncology
The Elephant in the Room: Addressing Oncology’s Carbon Footprint

From travel-related emissions to medical waste, Drs. Puneeth Iyengar and Edward Christopher Dee discuss the environmental impact of radiotherapy. Read more

No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Heidi Nafman-Onda
on: January 07, 2025In: Names & News, Patient Advocacy, Radiation Oncology
No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Heidi Nafman-Onda, founder of The White Ribbon Project, shares her experience discovering and grappling with the long-term effects of radiation therapy and addresses the need for coordinated survivorship care. Read more

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions

Grace Lee, MD
+more
on: February 13, 2024In: Evolving Standards of Care, Radiation Oncology
Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions

In part 2 of our look at AI’s impact on radiotherapy, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, discuss how AI may be leveraged when delivering radiotherapy, including improving our ability to predict treatment response and adverse events. Read more

Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning

Grace Lee, MD
+more
on: January 23, 2024In: Evolving Standards of Care, Radiation Oncology
Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning

In part 1 of a 2-part article, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, explore the possibilities and limitations of AI applications. Read more

Guideline Taskforce Chairs Discuss Need for Caution, Multidisciplinary Decision-Making When Using Definitive Radiotherapy for Oligometastatic NSCLC

Erin Jungmeyer
on: January 23, 2024In: Evolving Standards of Care, Radiation Oncology
Guideline Taskforce Chairs Discuss Need for Caution, Multidisciplinary Decision-Making When Using Definitive Radiotherapy for Oligometastatic NSCLC

In an interview with ILCN, Drs. Puneeth Iyengar and Matthias Guckenberger said despite a lack of phase III data in this space, science-based recommendations are needed to optimize multimodal therapy. Read more

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

Famke L. Schneiders, MD, PhD
+more
on: January 09, 2024In: Evolving Standards of Care, Radiation Oncology
Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

Drs. Famke L. Schneiders and Suresh Senan explore evidence that supports the use of radiotherapy to prime the immune system to maximize the benefits of immunotherapy. Read more

Patterns of Failure after PACIFIC: How to Address Disease Recurrence after Chemoradiotherapy and Immunotherapy

Cole M. Friedes, MD
+more
on: January 09, 2024In: Evolving Standards of Care, Radiation Oncology
Patterns of Failure after PACIFIC: How to Address Disease Recurrence after Chemoradiotherapy and Immunotherapy

Dr. Cole M. Friedes and colleagues analyzed progression patterns in patients after receiving the PACIFIC regimen and showed that many patients are candidates for further ablative treatments. Read more

Data Support IMRT as Standard of Care for Locally Advanced NSCLC

Fred Gebhart
on: November 21, 2023In: Meeting News, Radiation Oncology, WCLC News
Data Support IMRT as Standard of Care for Locally Advanced NSCLC

During the 2023 World Conference on Lung Cancer, Dr. Stephen Chun said long-term data show intensity-modulated radiation therapy offers an overall survival benefit and reduced toxicity compared to 3D conformal radiation therapy. Read more

Comparing Thoracic Radiotherapy Regimens for Limited Stage Small Cell Lung Cancer

Jeffrey A. Bogart, MD
on: November 07, 2023In: Radiation Oncology
Comparing Thoracic Radiotherapy Regimens for Limited Stage Small Cell Lung Cancer

Dr. Jeffrey A. Bogart says that despite evidence that twice-daily radiotherapy has positive impacts on survival, the treatment has not been routinely adopted. However, considerable uncertainty remains regarding the optimal dose of once-daily radiotherapy. Read more

12345

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy